Back
BP PLC Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
51
BP
BP PLC
Last Price:
$34.41
Seasonality Move:
4.04%
Sell
41
ALNY
Alnylam Pharmaceuticals
Last Price:
$269.17
Seasonality Move:
3.3%
Sell
41
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $269.21. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BP Stock Price Chart
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $269.21The current trend is moderately bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
BP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.51 | Buy |
Relative Strength Index (14 RSI): | 61.78 | Buy |
Chaikin Money Flow: | -5909147 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.21 - 34.51) | Buy |
Bollinger Bands (100): | (29.1 - 33.06) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.33 | Buy |
Relative Strength Index (14 RSI): | 56.44 | Buy |
Chaikin Money Flow: | -958699 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (238.07 - 265.67) | Buy |
Bollinger Bands (100): | (240.5 - 271.04) | Buy |
BP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.34 | Buy |
20-day SMA: | 33.12 | Buy |
50-day SMA: | 32.72 | Buy |
200-day SMA: | 32.42 | Buy |
8-day EMA: | 34.12 | Buy |
20-day EMA: | 33.57 | Buy |
50-day EMA: | 32.73 | Buy |
200-day EMA: | 32.69 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 266.08 | Buy |
20-day SMA: | 252.48 | Buy |
50-day SMA: | 259.02 | Buy |
200-day SMA: | 252.75 | Buy |
8-day EMA: | 268.02 | Buy |
20-day EMA: | 259.47 | Buy |
50-day EMA: | 256.9 | Buy |
200-day EMA: | 244.06 | Buy |
BP PLC Earnings Growth & BP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.19 per share, a decrease this year of $0.18 per share, and an increase next year of $0.25 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
BP PLC Technical Analysis
Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |